Carried by: Defiscience
References:
Clinician(s): Pr DELORME, Dr MARUANI, Dr David GERMANAUD, Dr Laurence PERRIN
Biologist(s): Dr TABET, Pr Thomas BOURGEON
Presentation
Autism spectrum disorders & early and severe neurodevelopmental disorders: a common and severe clinical presentation.
Objectives of pre-indications:
- Better assess the impact of genomic variations
- Offer high-level genetic expertise to populations
- Reduce costs associated with diagnostic uncertainty (multiple consultations, reassessments, additional opinions, etc.)
Expected benefits of WGS and specific features related to pre-indication:
- Detection and estimation of individual risk in monogenic disorders
- Increased diagnostic yield (C Yuen RK, 2017; Niemi, 2018; Lakoucheva, 2019)
- Better risk estimates: early management for at-risk families
- Integration of genome-wide data into a broader assessment of the contribution of genomic variation to complex neurodevelopmental disorders, including evaluation of the contribution of polygenic risk scores.
Criteria before considering a discussion in MDM-FMG
These criteria are listed in the prescription guidance form (available in French), which can be accessed via the following link.
MDM-FMG procedures:
- The national upstream MDM-FMG, coordinated by Robert-Debré Hospital (the lead centre for this pre-indication), centralises requests. Meetings are held monthly on the second Thursday of each month at 2:00 p.m. Eligibility is assessed based on the prescription guidance form submitted by email to rcp-tsatnd-nationale.rdb@aphp.fr.
- The prescribing clinician is not required to attend the MDM-FMG meeting by videoconference but may do so if they wish to discuss the case or resubmit a previously non-approved case.
- Please notify the coordinating team when the form has been sent by email.
- The MDM-FMG decision will be communicated to the prescribing clinician by email.
- Once a favourable opinion has been received from the national MDM-FMG, the completed form must be uploaded to Spice/Hygen when submitting the electronic prescription.
Genome Sequencing in diagnostic strategy

MDM
Type of the MDM
City of the coordinator
Name, first name, and email of the contact
MDM ASD-NDD Robert Debré
Local
Paris
Richard DELORME
Anna MARUANI
Laurence PERRIN
David GERMANAUD
MDM ASD-NDD Necker
Local
Paris
Maya VILAYLEK
MDM ASD-NDD Versailles
Local
Versailles
MDM ASD-NDD Tours
Local
Tours
MDM ASD-NDD Nantes
Local
Nantes
MDM ASD-NDD Dijon
Local
Dijon
MDM ASD-NDD Montpellier
Local
Montpellier
MDM ASD-NDD Strasbourg
Local
Strasbourg
